JPMorgan Upgrades Afya to Buy, Sees R$1.8B Synergies from Yduqs Merger

JPMorgan raised its recommendation on Afya to buy, incorporating estimates of the merger with Yduqs, which is expected to generate R$1.8 billion in synergies. The upgrade reflects analyst confidence in the deal's value creation, though the merger's completion and regulatory approvals remain uncertain. This signals positive sentiment for Afya's stock and the broader Brazilian education sector.